Direct-to-Patient Clinical Trials: One Small Step or a Giant Leap?

ABSTRACT: Genome driven precision oncology has transformed the landscape of multiple cancers. However, access barriers exist. A recent study exemplified a direct-to-patient outreach program via social media through the implementation of a global program that offered free tumor genomic testing with a focus on rare cancers. See related article by Doe-Tetteh et al., p. 2445.

SUBMITTER: Desai A 

PROVIDER: S-EPMC10330328 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature